Hinge Health Inc. (NYSE:HNGE) Stock Has Consensus Target Price of $108.00

Shares of Hinge Health Inc. (NYSE:HNGE) have earned a consensus rating of “Moderate Buy” from the nineteen research firms that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, fifteen have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $108.00.

A number of equities analysts have weighed in on HNGE shares. Stifel Nicolaus upped their price target on Hinge Health from $115.00 to $130.00 and gave the stock a “buy” rating in a research report on Monday, October 26th. Wells Fargo & Company lifted their price objective on shares of Hinge Health from $90.00 to $103.00 and gave the company an “overweight” rating in a report on Wednesday, August 5th. Royal Bank Of Canada lifted their price objective on shares of Hinge Health from $75.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Weiss Ratings lowered shares of Hinge Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, October 8th. Finally, Canaccord Genuity Group set a $105.00 target price on shares of Hinge Health in a research report on Wednesday, August 5th.

Hinge Health Price Performance

Shares of Hinge Health stock opened at $114.06 on Thursday. The firm has a market cap of $9.20 billion, a price-to-earnings ratio of 89.11 and a beta of 1.37. The stock’s 50-day moving average is $98.13 and its 200-day moving average is $67.01. Hinge Health has a one year low of $30.08 and a one year high of $117.55.

Hinge Health (NYSE:HNGE) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.31. Hinge Health had a return on equity of 51.60% and a net margin of 15.15%. The company had revenue of $212.82 million during the quarter. During the same period in the prior year, the company earned $0.59 earnings per share. The firm’s quarterly revenue was up 53.0% on a year-over-year basis. On average, equities analysts expect that Hinge Health will post 1.25 EPS for the current year.

Insider Buying and Selling at Hinge Health

In other Hinge Health news, CEO Daniel Perez sold 4,100 shares of the business’s stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $100.20, for a total transaction of $410,820.00. Following the sale, the chief executive officer directly owned 4,100 shares of the company’s stock, valued at $410,820. The trade was a 50.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO James Budge sold 47,720 shares of the stock in a transaction dated Monday, October 12th. The stock was sold at an average price of $103.13, for a total transaction of $4,921,363.60. Following the transaction, the chief financial officer owned 296,728 shares of the company’s stock, valued at approximately $30,601,558.64. This represents a 13.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 1,024,581 shares of company stock valued at $95,632,761. Corporate insiders own 18.92% of the company’s stock.

Institutional Trading of Hinge Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. IFP Advisors Inc lifted its stake in Hinge Health by 140.0% in the second quarter. IFP Advisors Inc now owns 324 shares of the company’s stock valued at $27,000 after acquiring an additional 189 shares during the last quarter. Nykredit A S bought a new position in shares of Hinge Health in the 2nd quarter valued at about $29,000. SBI Securities Co. Ltd. grew its position in shares of Hinge Health by 39.5% in the 3rd quarter. SBI Securities Co. Ltd. now owns 364 shares of the company’s stock valued at $35,000 after acquiring an additional 103 shares during the period. Sterling Capital Management LLC increased its stake in shares of Hinge Health by 899.3% during the 3rd quarter. Sterling Capital Management LLC now owns 1,469 shares of the company’s stock worth $143,000 after purchasing an additional 1,322 shares during the last quarter. Finally, Vise Technologies Inc. acquired a new position in shares of Hinge Health during the 3rd quarter worth about $207,000.

Hinge Health Company Profile

Hinge Health is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care programs designed to help members manage pain, improve mobility and reduce the need for more costly or invasive treatments.

Its platform combines personalized exercise therapy, behavioral support, education and access to clinical professionals. Hinge Health also uses technologies such as motion-sensing wearable devices and artificial intelligence to help guide exercises, monitor progress and tailor care plans to individual needs.

Hinge Health primarily serves employers and health plans, which offer its programs to eligible members in the United States.